ICCM Stock Risk & Deep Value Analysis

IceCure Medical Ltd

DVR Score

8.1

out of 10

Hidden Gem

The Bottom Line on ICCM

We analyzed IceCure Medical Ltd using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran ICCM through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Sep 15, 2025•Run Fresh Analysis →

ICCM Deep Value Analysis

IceCure demonstrates strong 10x potential with its ProSense cryoablation system, validated by exceptional 5-year ICE3 trial data for breast cancer, a significant and largely untapped market for non-surgical options. This provides a crucial competitive moat. Rapid revenue growth (100%+ YoY) and recent institutional funding confirm positive momentum and extend cash runway. Leadership has successfully navigated regulatory hurdles. While high cash burn and potential for future dilution remain risks, the clear differentiation and critical clinical validation make it a compelling high-risk, high-reward opportunity, far from a dud.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More